Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 39,062 shares at $1.82 ($68K) on 2023-06-06, disclosed to the SEC on 2023-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.67 | 20,000 | $33K | 49.1% |
| 2 | $1.82 | 19,062 | $35K | 50.9% |
| Total | $1.74 avg | 39,062 | $68K | 100% |
| Filing → |
| HCWB | BUY | 2023-09-15 | $11K | — | Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |